GAMIMUNE N 10% (IV)

Approval Id: 429e889e790837ac
Drug Approval Canada Name: GAMIMUNE N 10% (IV)
Product Name: GAMIMUNE N 10% (IV)
Status: Cancelled Post Market
Status Date: 2006-08-03
Original Market Date: 2000-05-16
Din: 02229695
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 80:04.00
Atc Original: J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Atc Name: j 06 ba 02
Aig Number: 0106267005
Company Name: TALECRIS BIOTHERAPEUTICS INC
Company Address: 8368 Us 70 Business Hwy. West, Clayton, North Carolina, United States, 27520-9464
Company Detail Path: /organization/talecris-biotherapeutics-inc-raleigh-north-carolina-united-states

IMMUNOGLOBULIN (HUMAN)

100 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

429e889e790837ac

Type

Standard